tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ABBV Stock Latest News

AbbVie Completes $8 Billion Senior Notes Financing Offering
Company AnnouncementsAbbVie Completes $8 Billion Senior Notes Financing Offering
2d ago
8K
ABBV
AbbVie Advances Venetoclax Into Rare Blood Cancers With New Phase 2 Study
PremiumCompany Announcements
AbbVie Advances Venetoclax Into Rare Blood Cancers With New Phase 2 Study
3d ago
ABBV
AbbVie’s neuroendocrine carcinoma treatment granted FDA orphan designation
PremiumThe Fly
AbbVie’s neuroendocrine carcinoma treatment granted FDA orphan designation
5d ago
ABBV
AbbVie reports ‘positive’ results from Phase 3 AFFIRM study of Skyrizi
PremiumThe Fly
AbbVie reports ‘positive’ results from Phase 3 AFFIRM study of Skyrizi
5d ago
ABBV
Uber, Verizon, AbbVie, IBM and McDonald’s Insider Shake-Up
PremiumWeekend Updates
Uber, Verizon, AbbVie, IBM and McDonald’s Insider Shake-Up
7d ago
VZ
IBM
AbbVie’s SKYRIZI Lactation Study Completion Adds Quiet Support to Its IBD Growth Story
PremiumCompany AnnouncementsAbbVie’s SKYRIZI Lactation Study Completion Adds Quiet Support to Its IBD Growth Story
8d ago
ABBV
AbbVie’s XEN45 Glaucoma Study Signals New Angle in Eye Care Strategy
Premium
Company Announcements
AbbVie’s XEN45 Glaucoma Study Signals New Angle in Eye Care Strategy
8d ago
ABBV
AbbVie’s Upadacitinib Study in Teens With Eczema: Fresh Real‑World Data Investors Should Watch
Premium
Company Announcements
AbbVie’s Upadacitinib Study in Teens With Eczema: Fresh Real‑World Data Investors Should Watch
8d ago
ABBV
AbbVie Announces $7.5 Billion Senior Notes Offering
PremiumCompany Announcements
AbbVie Announces $7.5 Billion Senior Notes Offering
8d ago
8K
ABBV
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
PremiumThe Fly
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
9d ago
PFE
ABBV
AbbVie initiated with an Outperform at RBC Capital
PremiumThe Fly
AbbVie initiated with an Outperform at RBC Capital
10d ago
ABBV
AbbVie’s Real‑World Vraylar Study in Bipolar I Disorder Reaches Completion
PremiumCompany Announcements
AbbVie’s Real‑World Vraylar Study in Bipolar I Disorder Reaches Completion
11d ago
ABBV
AbbVie Advances ABBV-8736 With New Trial Comparing Injection Routes
PremiumCompany AnnouncementsAbbVie Advances ABBV-8736 With New Trial Comparing Injection Routes
12d ago
ABBV
AbbVie to invest $380M in two API manufacturing facilities at Illinois campus
Premium
The Fly
AbbVie to invest $380M in two API manufacturing facilities at Illinois campus
12d ago
ABBV
Ideaya Biosciences appoints Theodora Ross as chief development officer
Premium
The Fly
Ideaya Biosciences appoints Theodora Ross as chief development officer
12d ago
ABBV
IDYA
AbbVie Expands IPF Pipeline With New Phase 2a Study of ABBV-142
PremiumCompany Announcements
AbbVie Expands IPF Pipeline With New Phase 2a Study of ABBV-142
15d ago
ABBV
Barclays Bank (BCS) Names Four Pharma Stocks to Buy Now
PremiumMarket News
Barclays Bank (BCS) Names Four Pharma Stocks to Buy Now
15d ago
BCS
BMY
FDA approves AbbVie venclexta, acalabrutinib supplemental new drug application
PremiumThe Fly
FDA approves AbbVie venclexta, acalabrutinib supplemental new drug application
15d ago
ABBV
AbbVie initiated with an Overweight at Barclays
PremiumThe Fly
AbbVie initiated with an Overweight at Barclays
15d ago
ABBV
AbbVie’s ABBV-547 First‑in‑Human Trial: What Early Pipeline Moves Mean for ABBV Investors
PremiumCompany AnnouncementsAbbVie’s ABBV-547 First‑in‑Human Trial: What Early Pipeline Moves Mean for ABBV Investors
17d ago
ABBV
AbbVie’s VOLITE Skin Quality Trial Completion: What It Means for ABBV Investors
Premium
Company Announcements
AbbVie’s VOLITE Skin Quality Trial Completion: What It Means for ABBV Investors
17d ago
ABBV
AbbVie price target raised to $299 from $289 at Piper Sandler
Premium
The Fly
AbbVie price target raised to $299 from $289 at Piper Sandler
17d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >